Recent Announcements

America's State of Mind: New Report Finds Americans Increasingly Turn to Medications to Ease their Mental Woes; Women Lead the Trend

Medco Research Institute’s Weight Loss Abstract a Peer-Nominated Finalist at ISPOR in Madrid, Spain
ISPOR (International Society for Pharmacoeconomics and Outcomes Research)

Medco Research Institute Study Shows Some Patients Discontinue New Anticoagulant Drug Early, Which May Increase Stroke Risk

Archon Genomics X Prize Presented by Medco is an initiative for scientific teams to rapidly, accurately and economically sequence 100 whole human genomes – the 6 billion bases that make up the DNA within the 46-chromosome diploid genome in each human cell – to a level of accuracy never before achieved

A Real-World Evaluation of Adherence and Persistence of weigh-Loss Pharmacotherapy in the United States: 2007-2010. Value in Health, Volume 14, Issue 3, May 2011, Page A64.

Impact of an adherence program, run as a telephone intervention on compliance with subcutaneous interferon β-1a for multiple sclerosis patients using a mail-order pharmacy – 1 year results.

Benchmark Analysis of Genetic Testing Practice Patterns in a Real-World Population of Patients Receiving Clopidogrel or Prasugrel Therapy.

Comparison of Real-World Adherence and Persistence of Prasugrel and Clopidogrel Therapy

Medco, Quest Diagnostics Personalized Medicine Study Yields Additional Clues about Patient Engagement

Putting Gene Tests to Use: More Than a Third of Patients Cannot Properly Metabolize Plavix®

Preference for genetic testing among patients offered participation in the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial.